Aptinyx - Stock Price History | APTX

Historical daily share price chart and data for Aptinyx since 2021 adjusted for splits. The latest closing stock price for Aptinyx as of September 27, 2021 is 2.50.
  • The all-time high Aptinyx stock closing price was 31.85 on September 10, 2018.
  • The Aptinyx 52-week high stock price is 6.47, which is 158.8% above the current share price.
  • The Aptinyx 52-week low stock price is 2.16, which is 13.6% below the current share price.
  • The average Aptinyx stock price for the last 52 weeks is 3.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Aptinyx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.4953 3.6800 5.0300 1.8100 3.4600 1.17%
2019 4.4297 17.2500 19.3300 2.8400 3.4200 -79.32%
2018 23.8492 20.2000 31.8500 16.1500 16.5400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.169B $0.002B
Aptinyx Inc. is a bio-pharmaceutical company. It focuses on discovery, development, and commercialization of novel, proprietary and synthetic small molecules for the treatment of brain and nervous system disorders. The company's product pipeline consists of NYX-2925, NYX-783 and NYX-458 which are in clinical stage. Aptinyx Inc. is based in IL, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29